Inspire Medical Systems (INSP) Research & Development (2017 - 2026)

Inspire Medical Systems has disclosed Research & Development across 10 years of filings, most recently posting $24.7 million for Q2 2026.

• In Q2 2026, Research & Development fell 5.77% year-over-year to $24.7 million; the TTM figure through Jun 2026 stood at $99.7 million (down 9.74% YoY), while the FY2025 annual figure was $103.2 million, down 9.61% from the prior year.
• Research & Development came in at $24.7 million for Q2 2026 at Inspire Medical Systems, down from $25.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $31.1 million in Q4 2023 to a low of $11.9 million in Q1 2022.
• Average Research & Development over 5 years is $25.2 million, with a median of $26.0 million recorded in 2024.
• Year-over-year, Research & Development surged 118.36% in 2022 and declined 17.78% in 2025.
• Over 5 years, Research & Development stood at $21.2 million in 2022, then jumped by 46.14% to $31.1 million in 2023, then declined by 2.31% to $30.3 million in 2024, then slipped by 17.78% to $24.9 million in 2025, then decreased by 0.98% to $24.7 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $24.7 million in Q2 2026, $25.8 million in Q1 2026, and $24.9 million in Q4 2025.